MiR-29 sponge, nucleic acid construct containing same and applications of miR-29 sponge
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- NANJING MEDICAL UNIV
- Publication Date
- 2021-01-15
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of biomedicine, and in particular relates to a miR-29 sponge inhibiting miR-29, a nucleic acid construct comprising the miR-29 sponge and its application in preparing medicines for treating or preventing type 1 diabetes. Background technique
[0002] Diabetes mellitus (DM) has become a common and frequently-occurring disease that seriously affects human health in modern society. According to the latest IDF report, as of 2019, approximately 463 million adults aged 20-79 worldwide suffer from diabetes. Although type 2 diabetes accounts for 90-95%, the prevalence of type 1 diabetes is also increasing at a rate of 2% to 5%, among which the incidence rate of children and adolescents under the age of 15 is the fastest growing. Although the incidence of type 1 diabetes is not as high as that of type 2 diabetes, it has a rapid onset, tends to be younger, and causes serious complications such as ketoacidosis and hyp...